Journal
ACS CHEMICAL BIOLOGY
Volume 5, Issue 5, Pages 489-497Publisher
AMER CHEMICAL SOC
DOI: 10.1021/cb100011u
Keywords
-
Categories
Funding
- National Science Council (NSC) [97-2628-M-001-016-MY3, 95-2113-M001-027-MY3]
- Academia Sinica, Taiwan
Ask authors/readers for more resources
Human N-acetyl-beta-hexosaminidase (Hex) isozymes are considered to be important targets for drug discovery. They are directly linked to osteoarthritis because Hex is the predominant glycosidase released by chondrocytes to degrade glycosaminoglycan. Hex is also associated with lysosomal storage disorders. We report the discovery of GlcNAc-type iminocyclitiols as potent and selective Hex inhibitors, likely contributed by the gain of extra electrostatic and hydrophobic interactions. The most potent inhibitor had a K-i of 0.69 nM against human Hex B and was 2.5 x 10(5) times more selective for Hex B than for a similar human enzyme O-GlcNAcase. These glycosidase inhibitors were shown to modulate intracellular levels of glycolipids, including ganglioside-GM2 and asialoganglioside-GM2.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available